Retinitis pigmentosa is a hereditary eye disease that is characterized by a genetic defect in the pigment epithelium, resulting in poor vision in darker places, night blindness, and decreased visual acuity. As the disease progresses, patients gradually lose peripheral vision, manifesting central vision impairment or even blindness, thus affecting the quality of life. Clinical retinitis pigmentosa can be treated to improve the symptoms, but it cannot be eradicated.1. General treatment: You can have your eyesight checked in the hospital and wear visual aids to improve your vision. In addition, wear sunglasses when going out to protect your eyes and reduce the damage caused by ultraviolet rays. 2. Medication: Patients with retinitis pigmentosa usually need to supplement with exogenous vitamin A preparations, which can slow down the progression of retinitis pigmentosa and at the same time increase the ability to see at night to a certain extent. In addition, doctors use antioxidants and calcium channel blockers to slow down the apoptosis of visual cells and slow down the degenerative vision process. With the advancement of medical technology, there are gene therapy drugs and neurotrophic factors, which can be used in the treatment of this disease to achieve better results; 3. Surgery: For patients with more serious conditions, surgical treatment can be attempted to implant a visual prosthesis to help patients restore their vision. In addition, Chinese medicine believes that retinitis pigmentosa is mostly caused by the deficiency of liver and kidney, resulting in loss of vision, so Chinese medicine for patients with retinitis pigmentosa, clinical treatment is mostly taken to warm the kidney yang, tonifying the liver and kidney to improve the purpose of the treatment, with acupuncture and other methods of adjuvant therapy. However, Chinese medicine has not achieved a clear therapeutic effect, and clinical trials are ongoing in the hope of stabilizing the patient’s vision and field of vision, slowing down the progression of the disease, and delaying the patient’s time of blindness.